Navigation Links
California's Historic RN-to-Patient Hospital Staffing Ratios Upgraded Again With New Year
Date:1/3/2008

OAKLAND, Calif., Jan. 2 /PRNewswire/ -- California's historic safe hospital staffing law, achieved through years of advocacy by the California Nurses Association/National Nurses Organizing Committee, completes its phase-in period as ratios on several units were lowered on Jan. 1, 2008 to meet state mandates for minimum safe care.

Over the five year course of their phase-in, these ratios have revolutionized hospital care and improved patient safety by mandating that hospitals maintain minimum, specific nurse-to-patient staffing ratios for all hospital units at all times.

Because of their achievements, the ratios have sparked a brush fire around the country by nurses demanding similar laws in other states.

Ratios differ by hospital area, such as a minimum of no less than 1 RN for every 5 patients in general medical or post-surgical care units, 1:4 in pediatrics, and 1:4 in emergency rooms.

The ratios are a floor, not a ceiling, with hospitals also required to increase registered nurse staffing as needed based on individual patient illness or acuity.

As of Jan. 1, new ratios are in effect for three specific units. They are: 1:3 in Step Down (transitional units between intensive care and general medical-surgical floors, reduced from 1:4), 1:4 in Telemetry (where patients are on monitors, improved from 1:5) and 1:4 in Other Specialty Care units such as cancer care (upgraded from 1:5).

"California's ratios are a spectacular success story," said Zenei Cortez, RN, member of the CNA/NNOC Council of Presidents. "Under our ratio law, lives are being saved, our ability to be effective advocates for our patients is stronger, and more RNs are entering the work force and staying at the bedside longer, mitigating the nursing shortage."

Since the law was signed, 80,000 more licensed RNs have come into the state's workforce.

CNA/NNOC has sponsored similar proposed bills in Arizona, Illinois, Maine, Ohio, and Texas, and is
'/>"/>

SOURCE California Nurses Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Historic Abortion Case; Acuna V. Turkish
2. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
3. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
4. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
5. Historic Breast Cancer Global Advocate Summit Convenes in Budapest, Hungary on September 29-30
6. Asbestos No More: Historic Asbestos Ban Passage Imminent
7. A Breath of Fresh Air From Washington: Senate Passes Historic Asbestos Ban
8. NDPA Urges Passage of Historic Pool Bill
9. Historic Agreement Reached to More Expertly and Efficiently Expand Proton Therapy Worldwide
10. Historic Global Vigil for AIDS Orphans Ends in New York City
11. New research explores newborn in-hospital weight loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...cent research findings suggest that reflecting on ...logical responses to stress at low levels. Stress ... of a broad array of mental and physical health di...on the self suggest that self-affirming activities...
...ofessor Bruno DiGiovine and colleagues from Henry ...ople with lung cancer declined their interest to u...er rate than the white colored//. The study found ...s of lung cancer surgery and this misinformation h...
...riodontal disease is one of the main causes of too...ority of the tooth extractions (those with periodo...for those without// periodontal disease). It has n...tain groups of people exhibit increased susceptibi...
...lmon is considered a health food by many, because ..., its protein. A study compared the benefits of fa...// (mostly pacific salmon). Farmed salmon or Atla...e environmental pollutants such as mercury, PCBs, ...
Other Medicine News:Health News:Blacks decline Lung cancer surgery 2Health News:Nine Major Culprits For Tooth Loss Identified By Researchers 2Health News:Nine Major Culprits For Tooth Loss Identified By Researchers 3
(Date:10/6/2008)... Improve Patient Safety, WASHINGTON, Oct. 6 /PRNe...iology in collaboration with the American College ...tion today released consensus guidelines,outlining...rs and,gastrointestinal (GI) bleeding among patien...IDs) along with antiplatelet agents., Gastrointes...
(Date:10/6/2008)... Dosed Prior to Surgery, TAMPA, Fla., Oct. 6 /PRN... held ophthalmic-focused biopharmaceutical company...ophthalmic emulsion) 0.05% is now,commercially ava...od and,Drug Administration in June 2008, is a topi...eatment of inflammation and pain associated with o...
(Date:10/6/2008)...irstCall/ -- Genaera,Corporation (Nasdaq: GENR ) ...al trial of trodusquemine (MSI-1436), Genaera,s le...etes and obesity. MSI-1436 is a novel,inhibitor of... the function,of both the leptin and insulin pathw... the study, MSI-1436 was found to be well-tolerate...
(Date:10/6/2008)...patients achieved endoscopic,response and more tha... 10,in data from a 54-week open-label study presen...CG) Annual Scientific Meeting, ORLANDO, Fla., Oct...a,large, prospective study investigating endoscopi...gic compound. The data presented at the American,C...
Breaking Medicine Technology:Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Industry Executives Finding Value in Shift of Scientific Publications 5484 1Industry Executives Finding Value in Shift of Scientific Publications 5484 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2104 1Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2104 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2104 3Researchers expand natural killer cells in cord blood to fight leukemia 19605 1Researchers expand natural killer cells in cord blood to fight leukemia 19605 2New drug combination brings 1 2 punch against acute leukemia 19604 1New drug combination brings 1 2 punch against acute leukemia 19604 2
...13, 2007, 2007, SAN DIEGO, and SEOUL, South Korea,...euticals, Inc. and LG Life,Sciences, Ltd., present... (LB80380) retains potency against multiple mutant...stant to lamivudine,adefovir, entecavir or telbiv...nual Meeting of the European Association for the S...
...c Hepatitis B e-Antigen,(HBeAg)-Negative Patients ...Treatment, PRINCETON, N.J., April 13, 2007 /PRNews...day announced data from a cohort of,nucleoside-nai...V-027/901, n=99). These data showed that patients ...rus in the blood,after interruption of treatment w...
Other Medicine Technology:ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 2ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 3ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 4ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 5ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 6Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 2Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 3Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 4Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 5
Bacterial/Viral Filters for Anesthesia and Respiratory Applications
Bacterial/Viral Filters for Anesthesia and Respiratory Applications
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours.
Medicine Products: